Pharma executives make a move: recent appointments

28-Jun-2017 - Last updated on 29-Jun-2017 at 10:12 GMT

Daniel Jorgensen

Ocugen welcomes ex-Pfizer Daniel Jorgensen, the IGBMA’s Biosimilars Committee gets a new chair and drug development consultants Boyds hires two associate directors in one go.

Ocugen: Daniel Jorgensen

Syros Pharmaceuticals: Srinivas Akkaraju

IGBMA: Ingrid Schwarzenberger

Boyds: Elaine Harper & Jayne Hunt

Dragonfly Therapeutics: Nicolai Wagtmann

Products

Saama accelerates data review processes Saama | Download Infographic

Webinars

On-demand webinars

Diversity: Increasing trial inclusivity Webinar
How to reduce crosslinking and ensure fast dissolution in soft caps
Cell and Gene Therapy Manufacturing Webinar

Headlines

Thermo Fisher's new EU ultra-cold facility to boost advanced therapies development
EMA consolidates guidelines for computerized systems in clinical trials
EQT invests in CluePoints to boost AI-driven clinical trial data quality and compliance
IGC Pharma - unlocking new horizons in Alzheimer’s care with personalized medicine
Is Combogesic IV revolutionizing pain management in the US healthcare market?
New AI-powered tool streamlines trial feasibility and re-forecasting from start to finish
Sonara Health: Transforming methadone treatment access for opioid use disorder patients
How is uMotif empowering clinical trials with advanced eCOA technology?

Pharma executives make a move: recent appointments

Follow us

Products

Webinars

Headlines

Outsourcing-Pharma

Resources